SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Lupin
Lupin
BSE: 500257|NSE: LUPIN|ISIN: INE326A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Sep 19, 17:00
1401.55
24.2 (1.76%)
VOLUME 72,110
LIVE
NSE
Sep 19, 17:00
1400.85
23.35 (1.7%)
VOLUME 615,969
News on Lupin
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Prefer pharma, Tata Steel, Ambuja Cements: Sanju Verma 

12.28 pm | 18 Sep 2014 |  Source: CNBC-TV18

Sanju Verma, CEO at Violet Arc Global Managers is of the view that one may prefer pharma stocks, Tata Steel from the metal space and Ambuja Cements fr...

Mkt optimism to continue; upbeat on IT: Prabhudas Lilladher 

12.00 pm | 18 Sep 2014 |  Source: CNBC-TV18

R Sreesankar, Head of Institutional Equities at Prabhudas Lilladher is extremely bullish on the Indian IT sector....

Oct events litmus test for Nov upswing: Sanju Verma 

10.01 am | 18 Sep 2014 |  Source: CNBC-TV18

Verma is upbeat on Lupin despite its continuous run, but has reservations about Sun Pharma. ...

Buy Lupin; target of Rs 1512: Sharekhan

1.18 pm | 17 Sep 2014 |  Source: Moneycontrol.com

Sharekhan is bullish on Lupin and has recommended buy rating on the stock with a target of Rs 1512 in its September 16, 2014 research report....

Praful Bohra explains how Nirmal Bang plays pharma stocks 

1.01 pm | 17 Sep 2014 |  Source: CNBC-TV18

Praful Bohra of Nirmal Bang Institutional Equities feels Lupin’s deal with Merck Serano will help the former to make way into incremental markets. F...

Merck Serono deal to help Lupin in long term: Brokerages

12.31 pm | 17 Sep 2014 |  Source: Moneycontrol.com

With maintaining overweight rating on the stock, Morgan Stanley views this deal as a longer-term incremental positive to Lupin's current business mode...

Short Jindal Steel; buy Lupin, Vivimed Labs: Pankaj Jain 

12.05 pm | 17 Sep 2014 |  Source: CNBC-TV18

Pankaj Jain of Sunteck Wealthmax recommends going long in Vivimed Labs and Lupin....

Bull's Eye: Buy Lupin, HDFC; short HDIL, Reliance Capital 

8.56 am | 17 Sep 2014 |  Source: CNBC-TV18

Meghana V Malkan, malkansview.com advises buying Ranbaxy Labs for a target price of Rs 615 and selling Reliance Capital for a target price of Rs 495....

Here are top 10 stocks to watch on Sep 17 

8.31 am | 17 Sep 2014 |  Source: CNBC-TV18

Here are top 10 stocks to watch on Sep 17 - Bharti Airtel, Maruti, Sun Pharma, Lupin, Cipla, Venus Remedies, JSW Steel, Future Retail, GMR Infra and U...

Lupin-Merck Serano ink pact to expand across EMs 

6.00 pm | 16 Sep 2014 |  Source: CNBC-TV18

This is a long-term deal and rings in positives for Lupin in terms of fixed milestone payments and expansions in emerging markets. Besides, they do no...

Accumulate Lupin for long term: Phani Sekhar 

5.03 pm | 16 Sep 2014 |  Source: CNBC-TV18

Phani Sekhar of Angel Broking is of the view that one can accumulate Lupin for long term....

See no incremental gains for Lupin in FY15-16: Surajit Pal 

4.30 pm | 16 Sep 2014 |  Source: CNBC-TV18

The pharmaceutical company Lupin has entered into a long-term strategic partnership with Merck Serono, the biopharmaceutical division of Merck. Howeve...

Lupin down 4.5% despite partnership deal with Merck Serono

3.37 pm | 16 Sep 2014 |  Source: Moneycontrol.com

Lupin and Merck agreed not to release any financial details of the transaction. The day before, media reports had suggested that the deal might be mor...

Lupin announces strategic alliance for emerging markets

2.45 pm | 16 Sep 2014 |  Source: Moneycontrol.com

Lupin announced today that it has entered into a long-term strategic partnership with Merck Serono, the Biopharmaceutical division of Merck....

Signs of recovery? Advance tax for 14 cos up 19% 

8.57 pm | 15 Sep 2014 |  Source: CNBC-TV18

CNBC-TV18 learns that most public sector banks, who’ve been facing NPA concerns, have surprisingly seen an increase in their advance tax payments. ...

Lupin-Merck KGaA complex generic deal likely in 1-2 days 

4.42 pm | 15 Sep 2014 |  Source: CNBC-TV18

The deal will see both companies signing a development, manufacturing and distribution pact for complex-generics....

Lupin hits record high, may sign big deal with Merck Serono

2.00 pm | 15 Sep 2014 |  Source: Moneycontrol.com

Citi says business development remains a core part of Lupin's growth strategy, with the latest deal (Salix) providing it a good foothold in Canada....

Hope rally over: Why you should go back to 'boring sectors'

12.36 pm | 15 Sep 2014 |  Source: Moneycontrol.com

“The Street is building in a capex cycle of the likes in 2004 and 2008,” Elara says, adding, “while we do not dispute the recovery signals, we a...

Lupin and Salix announce exclusive distribution agreement

3.40 pm | 12 Sep 2014 |  Source: Moneycontrol.com

Lupin and Salix Pharmaceuticals have entered into a definitive distribution agreement under which Salix has granted Lupin the exclusive right to marke...

See upside in Lupin: Vishal Malkan 

3.28 pm | 12 Sep 2014 |  Source: CNBC-TV18

Vishal Malkan of malkansview.com is of the view that one can see higher levels in Lupin....

1 2 3 4 5 6 7
Quick Links for Lupin
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.